SEC Form 4 · accession 0000905148-18-000733
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James B Weissman
Officer — Chief Business Officer
Period of report
Aug 17, 2018
Accepted (ET)
Aug 20, 2018 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2018 | M | 14,680 | $3.42 | A | 24,480 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.42 | Aug 17, 2018 | M | 14,680 | D | — | Sep 24, 2023 | Common Stock | 14,680 | 64,104 | D |
Explanation of responses
- F1This option vested 1/48 monthly on last day of each month with a vesting start date of 7/30/2013.